These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 6240150

  • 1. The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
    Allen JM, Williams G, O'Shea JP, Smith C, Yeo T, Kerle D, Bloom SR.
    Urol Res; 1984; 12(5):249-51. PubMed ID: 6240150
    [Abstract] [Full Text] [Related]

  • 2. Treatment of prostatic cancer by monthly injections of an LHRH-analogue depot.
    Hjertberg H, Varenhorst E, Svensson M, Kågedal B, Nordenskjöld B.
    Acta Oncol; 1988; 27(4):361-4. PubMed ID: 2974290
    [Abstract] [Full Text] [Related]

  • 3. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW, Uitterlinden P, de Jong FH.
    Cancer Res; 1988 Nov 01; 48(21):6063-8. PubMed ID: 2844399
    [Abstract] [Full Text] [Related]

  • 4. Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.
    Ahmann FR, Citrin DL, deHaan HA, Guinan P, Jordan VC, Kreis W, Scott M, Trump DL.
    J Clin Oncol; 1987 Jun 01; 5(6):912-7. PubMed ID: 2953870
    [Abstract] [Full Text] [Related]

  • 5. Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
    Schulze H, Senge T.
    J Urol; 1990 Oct 01; 144(4):934-41. PubMed ID: 2144596
    [Abstract] [Full Text] [Related]

  • 6. Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.
    Paisey RB, Kadow C, Bolton C, Hartog M, Gingell JC.
    J R Soc Med; 1986 Apr 01; 79(4):210-1. PubMed ID: 2939240
    [Abstract] [Full Text] [Related]

  • 7. Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetate.
    Schroeder FH, Lock TM, Chadha DR, Debruyne FM, Karthaus HF, de Jong FH, Klijn JG, Matroos AW, de Voogt HJ.
    J Urol; 1987 May 01; 137(5):912-8. PubMed ID: 2952810
    [Abstract] [Full Text] [Related]

  • 8. Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.
    Bruchovsky N, Goldenberg SL, Akakura K, Rennie PS.
    Cancer; 1993 Sep 01; 72(5):1685-91. PubMed ID: 7688656
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
    Moffat LE.
    Eur Urol; 1990 Sep 01; 18 Suppl 3():26-7. PubMed ID: 2151272
    [No Abstract] [Full Text] [Related]

  • 10. Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot LHRH analogue.
    Mahler C, Verhelst J, Chaban M, Denis L.
    Cancer; 1991 Feb 01; 67(3):557-9. PubMed ID: 1824680
    [Abstract] [Full Text] [Related]

  • 11. Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
    Di Silverio F, Sciarra F, D'Eramo G.
    Eur Urol; 1990 Feb 01; 18(1):10-5. PubMed ID: 2144819
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin].
    Wenderoth UK, Jacobi GH.
    Ann Urol (Paris); 1986 Feb 01; 20(2):95-7. PubMed ID: 3087269
    [Abstract] [Full Text] [Related]

  • 13. Testosterone and gonadotrophin profiles in patients on daily or monthly LHRH analogue ICI 118630 (Zoladex) compared with orchiectomy.
    Grant JB, Ahmed SR, Shalet SM, Costello CB, Howell A, Blacklock NJ.
    Br J Urol; 1986 Oct 01; 58(5):539-44. PubMed ID: 2946356
    [Abstract] [Full Text] [Related]

  • 14. Treatment of advanced carcinoma of the prostate by LHRH-agonists.
    Claes HI, Vandenbussche L, Vereecken RL.
    Prog Clin Biol Res; 1987 Oct 01; 243A():229-37. PubMed ID: 2958853
    [No Abstract] [Full Text] [Related]

  • 15. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.
    Varenhorst E, Wallentin L, Carlström K.
    Scand J Urol Nephrol; 1982 Oct 01; 16(1):31-6. PubMed ID: 6211762
    [Abstract] [Full Text] [Related]

  • 16. [Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
    Kuber W, Treu T, Kratzik C, Girsch E, Zeillinger R, Spona J.
    Wien Klin Wochenschr; 1990 Nov 09; 102(21):640-7. PubMed ID: 2148044
    [Abstract] [Full Text] [Related]

  • 17. Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation.
    Kreis W, Ahmann FR, Jordan VC, de Haan H, Scott M.
    Br J Urol; 1988 Oct 09; 62(4):352-4. PubMed ID: 2973364
    [Abstract] [Full Text] [Related]

  • 18. Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.
    Ahmed SR, Grant J, Shalet SM, Howell A, Chowdhury SD, Weatherson T, Blacklock NJ.
    Br Med J (Clin Res Ed); 1985 Jan 19; 290(6463):185-7. PubMed ID: 3155636
    [Abstract] [Full Text] [Related]

  • 19. Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
    Debruyne FM.
    Am J Clin Oncol; 1988 Jan 19; 11 Suppl 1():S33-5. PubMed ID: 2968760
    [Abstract] [Full Text] [Related]

  • 20. Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?
    Fernandez del Moral P, Litjens TT, Weil EH, Debruyne FM.
    Urology; 1988 Aug 19; 32(2):137-40. PubMed ID: 2969641
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.